Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2

Conditions

Anemia, Refractory, with Excess of Blasts 14Myelodysplastic Syndromes 13Leukemia, Myeloid, Acute 12Neoplasms 10Anemia 8Venous Thromboembolism 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Thrombocytopenia 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Lymphocytic, Chronic, B-Cell 5Primary Myelofibrosis 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Accelerated Phase 4Fanconi Anemia 4Burkitt Lymphoma 4Pulmonary Embolism 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Biphenotypic, Acute 3Leukemia 3Cytopenia 3Congenital Bone Marrow Failure Syndromes 3Blast Crisis 3Anemia, Aplastic 3Venous Thrombosis 2Uterine Cervical Neoplasms 2Recurrence 2Pathologic Complete Response 2Neutropenia 2

Interventions

Vancomycin 1Teicoplanin 1Ofloxacin 1Metronidazole 1Meropenem 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neutropenia × Classical hematology × 30 days × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡